Research and clinical trials for musculoskeletal tumors
City of Hope is a fully independent, biomedical research institution with the vision, drive and infrastructure to accelerate new treatment ideas from the laboratory to patients through clinical trials. Our onsite biologic manufacturing labs accelerate this process, as do our collaborative research efforts.
City of Hope’s Musculoskeletal Tumor Program pursues joint initiatives with colleagues on campus as well as with researchers nationwide. Complementing these efforts, we have the longest-standing cancer survivorship program in the country.
In a concerted effort to develop viable treatments that significantly improve cancer survival, musculoskeletal investigators collaborate across disciplines to develop the most promising therapies.
Some of our current research initiatives include:
- City of Hope’s Western Sarcoma Team has developed a unique web-based database to study the characteristics, treatment and outcome of many types of sarcomas and musculoskeletal tumors.
- A Phase II Study of Pazpanib in Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
- Childhood Cancer Survivor Study
- A COG Soft Tissue Sarcoma Biology and Banking Protocol
- City of Hope researchers are developing novel therapies that block musculoskeletal cancer's ability to proliferate and spread throughout the body; a phase I and II study of Dasatinib, an investigational drug that acts to inhibit cancer growth and invasion, has just been completed.